- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Sclerosis
Total 9910 results
-
IRCCS San RaffaeleFondazione Italiana Sclerosi MultiplaCompletedProgressive Multiple SclerosisItaly
-
Aristotle University Of ThessalonikiGreek Alzheimer's Association and Related Disorders; Ellis-Farm, Eliama Daily...CompletedProgressive Multiple SclerosisGreece
-
Duke UniversityCompletedPrimary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkBiogenCompletedPrimary Progressive Multiple SclerosisDenmark
-
MedDay Pharmaceuticals SATerminatedMultiple SclerosisUnited States, Spain, Canada, Australia, United Kingdom, Belgium, Turkey, Czechia, Poland, Italy, Hungary, Germany, Sweden
-
South Valley UniversityCompleted
-
University Hospital, BordeauxCompletedMultiple Sclerosis | Multiple Sclerosis, Acute RelapsingFrance
-
Genentech, Inc.No longer availableMultiple SclerosisUnited States
-
Novartis PharmaceuticalsTerminatedPrimary Progressive Multiple SclerosisUnited States, Belgium, Poland, Germany, Hungary, Turkey, Spain, Australia, Canada, Czechia, Switzerland, United Kingdom, Netherlands, France, Italy, Denmark, Finland, Sweden
-
Banner Life Sciences LLCCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Centre hospitalier de l'Université de Montréal...Genzyme, a Sanofi Company; Montreal Neurological Institute and HospitalCompleted
-
Stem Cell Medicine Ltd.WithdrawnSecondary Progressive Multiple Sclerosis (SPMS)Israel
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple Sclerosis (SPMS)Japan
-
Novartis PharmaceuticalsTerminatedDepression | Relapsing-remitting Multiple SclerosisGermany
-
Cionic, Inc.RecruitingMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Ospedale Policlinico San MartinoItalian Multiple Sclerosis Foundation; S. Andrea HospitalRecruiting
-
Neuromed IRCCSNot yet recruitingProgressive Multiple SclerosisItaly
-
Joanne Kurtzberg, MDRecruitingPrimary Progressive Multiple SclerosisUnited States
-
SanofiRecruitingPrimary Progressive Multiple SclerosisSpain, Italy, Turkey, India, Israel, Bulgaria, Mexico, Greece, Portugal, United States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Estonia, France, Georgia, Germany, Hungary, Japan and more
-
Hoffmann-La RocheRecruitingMultiple Sclerosis, Primary ProgressiveCanada, United States, Spain, Croatia, Serbia, Portugal, France, Tunisia, Mexico, Poland, Russian Federation, Australia, Belgium, Italy, United Kingdom, Ukraine, Bulgaria, Colombia, Georgia, Germany, Romania, New Zealand, Lebanon, Aus... and more
-
Fundació Institut Germans Trias i PujolClinica Universidad de Navarra, Universidad de NavarraRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingSpain
-
Immunic AGActive, not recruitingMultiple SclerosisUnited States, Germany, Netherlands, Bulgaria, Serbia, Canada, Czechia, Moldova, Republic of, North Macedonia, Poland, Romania, Ukraine
-
Turku University HospitalActive, not recruitingMultiple SclerosisFinland
-
Mapi Pharma Ltd.Active, not recruitingPrimary Progressive Multiple SclerosisIsrael, Moldova, Republic of
-
Terry L. WahlsCompleted
-
SanofiRecruitingMultiple SclerosisUnited States, Canada, Australia
-
University of CalgaryRecruiting
-
Danish Research Centre for Magnetic ResonanceScleroseforeningen; Danish Multiple Sclerosis CenterRecruitingPrimary Progressive Multiple SclerosisDenmark
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
University of NottinghamNottingham University Hospitals NHS TrustCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
University College, LondonUniversity of Leeds; University of Sheffield; Medical Research Council; Queen Mary... and other collaboratorsCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Isfahan University of Medical SciencesCompletedSecondary Progressive Multiple SclerosisIran, Islamic Republic of
-
BiogenTerminatedSecondary Progressive Multiple SclerosisUnited States, Finland, Italy, Spain, Canada, France, Israel, Sweden, Netherlands, Belgium, Poland, United Kingdom, Czechia, Denmark, Russian Federation, Germany, Ireland
-
Merck KGaA, Darmstadt, GermanyMerck Quimica Argentina S.A.I.CCompletedMultiple Sclerosis, Relapsing RemittingArgentina
-
Eli Lilly and CompanyBioMS Technology Corp.TerminatedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedSecondary Progressive Multiple SclerosisGermany
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom
-
Amanda IrishCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
University of IowaDJO Incorporated; Direct MS Canada; Pinnaclife Inc.; TZ Press, LLCCompletedMultiple SclerosisUnited States
-
National Institute of Neurological Disorders and...Terminated
-
Amphia HospitalSanofi; TEVA PharmachemieUnknown
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AG; Institut du Cerveau et de la Moelle épinièreRecruitingMultiple Sclerosis | Relapse | Primary Progressive Multiple SclerosisFrance
-
Rennes University HospitalRecruiting
-
Novartis PharmaceuticalsAvailable
-
University of VirginiaNational Multiple Sclerosis SocietyUnknownClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisUnited States
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
BiogenTerminatedMultiple Sclerosis, Secondary ProgressiveUnited States, Poland, Belgium, Slovakia, Czech Republic, Netherlands
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-remittingArgentina